Assay Development Team LeaderMeMed, Haifa, IsraelHaifa, Hefa, Israel
MeMed (Employee, Shareholder)
32 - Host Immune-Protein Signature Combining TRAIL, IP-10 and CRP for Early and Accurate Prediction of Severe COVID-19 Outcome
On Demand
